Use of cefroxadine dry syrup in the management of acute skin infections in children
Arata, J.; Yamamoto, Y.; Hagiyama, M.; Nohara, N.; Suwaki, M.; Miyoshi, K.; Masuda, T.; Nakagawa, S.; Ueki, H.; Nakakita, T.; Kashiwa, N.; Tokumaru, S.; Arakawa, K.; Take, M.; Nishihara, O.; Masuda, T.; Hiramatsu, H.; Yamada, M.; Nishimoto, M.; Tada, J.; Umemura, S.; Fujimoto, W.; Tanaka, A.; Okuma, N.
Japanese Journal of Antibiotics 34(12): 1748-1764
1981
ISSN/ISBN: 0368-2781 PMID: 7038191 Document Number: 170947
1. Cefroxadine dry syrup was in principle administered at the dosage of 10 mg per kilogram of body weight 3 times a day. 2. Evaluation was done in 4 grades, i.e. excellent, good, fair and poor. 3. According to subjective judgement by attending doctors, 'excellent' or 'good' was recorded in 90.7%. 4. If the evaluation was partially standardized, 'excellent' or 'good' was obtained in 74.8% of total 163 cases and in 78.7% of 108 impetigo cases. 5. Side effects were observed in 3 cases (diarrhea 1, fever 2). No direct correlation of these complaints with the administration of the present drug was confirmed.